Swaram Medicare And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 5.20 M
- Paid Up Capital ₹ 5.20 M
- Company Age 22 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 M
- Revenue Growth -32.26%
- Profit Growth -93.81%
- Ebitda -58.83%
- Net Worth 2.04%
- Total Assets -12.77%
About Swaram Medicare And Research Centre
Swaram Medicare And Research Centre Private Limited (SMARCPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 February 2002 and has a history of 22 years and 11 months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Corporate was formerly known as Swaram Medicare And Research Center Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.20 M and a paid-up capital of Rs 5.20 M.
The company currently has active open charges totaling ₹3.00 M.
Srinivasan Kumar and Balasubramanian Srinivasan serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85120TN2002PTC048441
-
Company No.
048441
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Feb 2002
-
Date of AGM
25 Apr 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Swaram Medicare And Research Centre?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srinivasan Kumar | Additional Director | 21-Jun-2023 | Current |
Balasubramanian Srinivasan | Additional Director | 27-Jun-2023 | Current |
Financial Performance of Swaram Medicare And Research Centre.
Swaram Medicare And Research Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.26% decrease. The company also saw a substantial fall in profitability, with a 93.81% decrease in profit. The company's net worth moved up by a moderate rise of 2.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Swaram Medicare And Research Centre?
In 2023, Swaram Medicare And Research Centre had a public holding of 16.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.30 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
05 Aug 2006 | Others | ₹3.00 M | Open |
How Many Employees Work at Swaram Medicare And Research Centre?
Unlock and access historical data on people associated with Swaram Medicare And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swaram Medicare And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swaram Medicare And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.